Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Cancers|November 26, 2022
Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional ExperienceJustin Jiang, Audrey M Sigmund, Qiuhong Zhao, et al.
Transplantation and Cellular Therapy|June 24, 2026
Outcomes of Tocilizumab for Cytokine Release Syndrome After Post-Transplant CyclophosphamideTuan L Phan, Roberta Azbell, Hannah Choe, et al.
JAMA Oncology|February 23, 2018
Prognostic Factors for Complete Response to Ibrutinib in Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of 2 Clinical TrialsSusan M O'Brien, Samantha Jaglowski, John C Byrd, et al.
Bone Marrow Transplantation|February 16, 2018
Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipientsDaniel R Richardson, Ying Huang, Heather L McGinty, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2014
Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host diseaseAreej El-Jawahri, Joseph Pidala, Yoshi Inamoto, et al.
Transplantation and Cellular Therapy|July 27, 2024
In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell TherapyChristopher E Dandoy, Joan Adams, Andrew Artz, et al.
Blood|September 20, 2017
Ibrutinib for chronic graft-versus-host disease after failure of prior therapyDavid Miklos, Corey S Cutler, Mukta Arora, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2024
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective StudyAdam S Kittai, David Bond, Ying Huang, et al.
Blood Advances|October 22, 2024
Siltuximab for chimeric antigen receptor T-cell therapy-related CRS and ICANS: a multicenter retrospective analysisAmneet Bajwa, Qiuhong Zhao, Marcus Geer, et al.
Blood|November 3, 2016
Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCTChristine E Ryan, Bita Sahaf, Aaron C Logan, et al.
Pageof 12